Show simple item record

dc.contributor.authorPRAMESTY, Intan Budi
dc.date.accessioned2025-08-04T07:41:10Z
dc.date.available2025-08-04T07:41:10Z
dc.date.issued2024-07-12
dc.identifier.nim201610101038en_US
dc.identifier.urihttps://repository.unej.ac.id/xmlui/handle/123456789/127711
dc.descriptionvalidasi_repo_ratna_Agustus 2025; Finalisasi oleh Taufik_Alya Tgl 4 Agustus 2025en_US
dc.description.abstractBackground: Recurrent Aphthous Stomatitis (RAS) is a common disorder characterized by recurrent ulcers limited to the oral mucosa. RAS is found in various ages, genders, and systemic diseases. RAS is divided into several classification types, minor, major and herpetiform types. RAS itself is not yet known for certain, but it is suspected that there are several predisposing factors, including hormonal changes, trauma, malnutrition, stress. The most common treatment for recurrent aphthous stomatitis (RAS) is pharmacological therapy and providing communication, educational information about RAS. Purpose: This study aims to determine the description of Recurrent Aphthous Stomatitis in patients at the Oral Medicine Department of RSGM Jember University in 2023 based on classification, general condition, suspected predisposing factors and management. Method: This research is a descriptive observational study with a research population of 722 data from the Department of Oral Medicine, RSGM Jember University in 2023. The number of samples that met the researchers' criteria was 171. Results: The results of the study showed that the prevalence of Recurrent Aphthous Stomatitis was 23.07% and The description of RAS patients is more common in women, namely 64.91% in men. Age 21-30 years is the vulnerable age for RAS 69.60%. Systemic factors causing RAS were mostly found in patients who did not experience symptoms of systemic factors, 91.22%. The type of RAS that often occurs is the minor type at 78.37%. The most predisposing factors were patients who had no suspected predisposing factors, 68.42%. Based on RAS management, pharmacological therapy is divided into two parts, namely topical pharmacological therapy 59.07% and supportive pharmacological therapy 40.93%. Topical therapy obtained is oxyfresh dental gel 79.20%, aloclair gel 13.87%,triamcinolone acetonide 6.93% and supportive therapy becomzet 91.43%, vitamin-c 7.14%, sangobion 1.43 %. All 171 SAR patients received 100% Communication, Information and Education services. Conclusion: Based on the research conducted, it can be concluded that SAR is often experienced by women in the 21-30 year age group, caused by stress and experiencing symptoms of anemia.en_US
dc.description.sponsorshipdrg. Ayu Mashartini Prihanti, Sp.PM Dr. drg. Erna Sulistiyani., M.Kesen_US
dc.language.isootheren_US
dc.publisherFakultas Kedokteran Gigien_US
dc.subjectRECURRENT APHTHOUS STOMATITISen_US
dc.subjectPREVALENCEen_US
dc.subjectRAS CLASSIFICATIONen_US
dc.subjectGENERAL CONDITIONen_US
dc.subjectSUSPECTED PREDISPOSING FACTORSen_US
dc.subjectMANAGEMENTen_US
dc.titleGambaran Stomatitis Aftosa Rekuren Pasien Klinik Ilmu Penyakit Mulut Rumah Sakit Gigi dan Mulut Universitas Jember Tahun 2023en_US
dc.typeSkripsien_US
dc.identifier.prodiPendidikan Dokter Gigien_US
dc.identifier.pembimbing1drg. Ayu Mashartini Prihanti, Sp.PMen_US
dc.identifier.pembimbing2Dr. drg. Erna Sulistiyani., M.Kesen_US
dc.identifier.validatorvalidasi_repo_ratna_Agustus 2025en_US
dc.identifier.finalizationTaufiken_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record